Announcement

Dr. Goodenowe Dietary Therapeutics LLC announces FDA-governed development pathway for nutrient-based compounds

February 20, 2026

Dr. Goodenowe Community Health Initiative Expands NeuroSupport Program to Serve Broader Neurodevelopmental Community

February 19, 2026

Dr. Dayan Goodenowe Announces FDA Clinical Development Program for a Novel Alzheimer’s Therapeutic

February 10, 2026

Dr. Dayan Goodenowe Announces Community Health Meal and Engagement Program for Moose Jaw Seniors

January 30, 2026

Dr. Dayan Goodenowe Announces Launch of Prodrome Science Japan

January 23, 2026

Dr. Dayan Goodenowe on Mitochondria and Cognitive Aging

January 13, 2026

Dr. Dayan Goodenowe and Autism Health Announce Dr. Goodenowe Childhood Neurodevelopmental Support Program – NeuroSupport

December 22, 2025

Plasmalogens, Advanced NeuroMRI, & Restoring the Aging Brain

December 12, 2025

Dr. Dayan Goodenowe Announces Partnership with Ruiya Group to Distribute Plasmalogen Precursors in China

October 15, 2025

Director’s Science Webinar: Unlocking Hope With Plasmalogen Restoration

October 13, 2025